96-12256. Advisory Committee on Immunization Practices: Announcement of Meeting and Request for Comments on Draft Poliomyelitis Statement

[Federal Register Volume 61, Number 96 (Thursday, May 16, 1996)]
[Notices]
[Page 24804]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-12256]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Advisory Committee on Immunization Practices: Announcement of 
Meeting and Request for Comments on Draft Poliomyelitis Statement

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Advisory Committee on Immunization Practices (ACIP).
    Times and Dates: 8:30 a.m.-6 p.m., June 19, 1996. 8:30 a.m.-2:45 
p.m., June 20, 1996.
    Place: CDC, Auditorium B, Building 2, 1600 Clifton Road, NE, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents.
    Matters to be Discussed: The Committee will discuss, among other 
items, the revision of the ACIP recommendation on poliomyelitis. 
Because of the considerable interest in the revised ACIP 
recommendation on poliomyelitis, there will be a public comment 
period on the morning of June 19, not to exceed three hours, during 
which members of the public will be able to address the ACIP members 
and executive staff of the CDC on the draft ACIP poliomyelitis 
prevention statement. This statement introduces a sequential 
schedule of inactivated poliovirus vaccine (IPV) followed by oral 
poliovirus vaccine (OPV) and includes the options of using any of 
three schedules: OPV alone, IPV alone or the sequential IPV--OPV 
schedule.
    Other topics to be discussed at the meeting include: measles, 
mumps, rubella (MMR) policy statement; MMR vaccination of HIV-
infected persons; a draft statement on acellular pertussis vaccine; 
the use of single antigen tetanus toxoid; a draft statement for 
rabies post-exposure treatment; an immunization update on varicella 
vaccine; a draft statement on reminder/recall systems; and achieving 
consistency among policy statements and vaccine package inserts. 
Other matters of relevance among the Committee's objectives may be 
discussed.
    Agenda items are subject to change as priorities dictate.
    Copies of the revised draft ACIP recommendation, ``Poliomyelitis 
Prevention in the United States: Introduction of A Sequential 
Schedule of Inactivated Poliovirus Vaccine (IPV) Followed by Oral 
Poliovirus Vaccine (OPV),'' are available to the public by notifying 
the contact person. Copies may be sent electronically upon request.
    Anyone wishing to make an oral presentation should submit their 
request, in writing, to the contact person by close of business June 
3, 1996. The request should include the name, address, and telephone 
number of the participant; the approximate time needed; and a copy 
of the presentation or a brief summary of the topic to be presented. 
Depending on the number of requests, up to six minutes will be 
allowed for each oral presentation. Anyone wishing to submit for 
consideration written comments regarding the revised ACIP 
recommendation on poliomyelitis prevention should submit the written 
comments to the contact person by June 13, 1996.
    Contact Person for More Information: Gloria A. Kovach, Committee 
Management Specialist, CDC (16-4346), 1600 Clifton Road, NE, M/S 
D50, Atlanta, Georgia 30333, Telephone [phone].

    Dated: May 10, 1996.
Nacny C. Hirsch,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 96-12256 Filed 5-15-96; 8:45 am]
BILLING CODE 4163-18-M